Back to Agenda
2018 Policy Mash-Up: New Shifts in the Healthcare Market and What They May Mean for Patients and the Biopharma Industry
Session Chair(s)
Nancy Bradish Myers, JD
CEO and Founder
Catalyst Healthcare Consulting, Inc, United States
The dynamics of the US healthcare market are shifting. Retailers are entering the world of healthcare in unorthodox ways; in one of the more prominent market shifts, we have seen a growing interest in consolidation between retail pharmacies and health plans. At the same time, Silicon Valley technology companies are looking to bring disruptive approaches to critical aspects of healthcare delivery. Shifts are also occurring on the public payer side; for example, new CMS policies will change the way states administer their Medicaid programs. How will all of these market changes impact biopharma innovators and patients? Come and hear from a range of experts about what’s triggering these market shifts, how they could affect care delivery, and what the future of healthcare may look like.
Learning Objective : Recognize shifts in the healthcare market that may signal important changes in care delivery or access to treatments; Appraise the potential impact and how biopharmaceutical and device stakeholders might strategize to prepare for such changes.
Speaker(s)
Panelist
Larry Kocot, JD
KPMG, United States
Principal, National Leader of the Center for Healthcare Regulatory Insight
Panelist
Darshak Sanghavi, MD
Optum Labs, United States
Chief Medical Officer and Senior Vice President of Translation
Panelist
Rick Weissenstein, MA
Cowen Washington Research Group, United States
Managing Director, Health Care Services and Pharmaceutical Policy
Have an account?